Respiratory Diseases (Pulmonology)

SAMIRA DTx S.L.

Heidi Rohwer, 13 July, 2026, 0

SAMIRA DTx Transform lives

VG2D Pharma

Heidi Rohwer, 8 July, 2026, 0

A First-in-Class Platform with Triple Efficacy in Cystic Fibrosis (CF)

heecap

Laura Lizama, 24 April, 2026, 0

Transforming breathing autonomy for the critically ill: smart, non-invasive muscle stimulation

Sleepiz AG

Max Sieghold, 16 July, 2025, 0

Contactless remote patient monitoring

MicroA

Heidi Rohwer, 11 July, 2025, 0

Anti-inflammatory and antiviral sustainable biologics targeting high unmet need in COPD

ATXA Therapeutics Ltd

Lilly Moran, 30 April, 2025, 0

A clinical stage pharma advancing proprietary novel drugs for a range of heart & lung diseases

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR

Aviso de cookies

Respiratory Diseases (Pulmonology)

SAMIRA DTx S.L.

VG2D Pharma

heecap

Sleepiz AG

MicroA

ATXA Therapeutics Ltd

Capital Cell Barcelona

Links

About cookies

Respiratory Diseases (Pulmonology)

SAMIRA DTx S.L.

VG2D Pharma

heecap

Sleepiz AG

MicroA

ATXA Therapeutics Ltd

Capital Cell Barcelona

Links

About cookies

Log in with your credentials

Forgot your details?

Create Account